| 00:00:00 | Characterization techniques suitable for drug delivery applications |
| 00:01:28 | Characterisation Techniques for Drug Delivery Systems |
| 00:02:18 | Contents |
| 00:03:13 | Contents |
| 00:03:24 | Instruments, Techniques and Parameters |
| 00:04:49 | Dynamic Light Scattering |
| 00:07:06 | DLS Size and Concentration Limits |
| 00:08:44 | Zeta Potential |
| 00:11:35 | Electrophoretic Light Scattering |
| 00:13:35 | Factors Affecting Zeta Potential |
| 00:15:13 | Static Light Scattering |
| 00:16:13 | Laser Diffraction (LALLS) |
| 00:16:58 | Contents |
| 00:17:16 | Microemulsions |
| 00:17:58 | Microemulsions |
| 00:20:30 | Liposomes |
| 00:21:58 | Liposome Composition: Anionic |
| 00:22:46 | Liposome Characterisation: Anionic |
| 00:23:45 | Liposome Composition: Cationic |
| 00:24:19 | Liposome Characterisation: Cationic |
| 00:24:35 | Cationic Liposomes in Gene Therapy |
| 00:25:21 | Cationic Liposomes in Gene Therapy |
| 00:27:36 | Coated Liposomes (Steric Stabilisation) |
| 00:29:44 | PEG-Coated Liposomes |
| 00:32:01 | Drug Delivery Nanoparticles: Effect of Cations |
| 00:33:35 | Stability of Solid Lipid Nanoparticles (SLN®) |
| 00:34:26 | Stability of Solid Lipid Nanoparticles (SLN®) |
| 00:35:21 | Stability of Solid Lipid Nanoparticles (SLN®) |
| 00:37:03 | Zetasizer Temperature Range Specifications |
| 00:38:35 | Size/Intensity Temperature Trend Measurements |
| 00:40:04 | Size/Intensity Temperature Trend Measurements |
| 00:41:07 | Functionalised Silica Nanoparticles |
| 00:41:33 | Functionalised Silica Nanoparticles |
| 00:42:47 | Functionalised Silica Nanoparticles |
| 00:43:44 | Functionalised Silica Nanoparticles |
| 00:44:38 | Functionalised Silica Nanoparticles |
| 00:45:43 | Conclusions |
| 00:47:28 | Further Information |
| 00:47:59 | Contact Information |
This webinar describes the use of light scattering techniques in drug delivery applications. Results obtained from various drug delivery systems will be discussed which will illustrate the information which can be obtained